| Literature DB >> 20496041 |
Mirjam K de Vries1, Anne S van Drumpt, Barend J van Royen, J Christiaan van Denderen, Radu A Manoliu, Irene E van der Horst-Bruinsma.
Abstract
The objective of this study is to investigate the prevalence of Andersson lesions (AL) in ankylosing spondylitis (AS) patients who will start anti-tumor necrosis factor (TNF) treatment. Radiographs and magnetic resonance imaging (MRI) of the spine were performed before therapy with anti-TNF. ALs were defined as discovertebral endplate destructions on MRI, associated with bone marrow edema and fat replacement or sclerosis, a decreased signal on T1, enhancement after contrast administration (gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA)), and increased signal on T2 and short tau inversion recovery (STIR). Additionally, conventional radiography showed a fracture line, irregular endplates, and increased sclerosis of adjacent vertebral bodies. Fifty-six AS patients were included, 68% males, mean age of 43 years, and mean disease duration of 11 years. The mean bath ankylosing spondylitis disease activity index was 6.4, and 24% of all patients had ankylosis. Only one patient showed a discovertebral abnormality with bone marrow edema of more than 50% of the vertebral bodies adjacent to the intervertebral disk of T7/T8 and T9/T10, a hypodense signal area on T1, and a high signal on STIR. Irregular endplates were depicted, and T1 after Gd-DTPA demonstrated high signal intensity around the disk margins. However, no fracture line was visible on conventional radiology, and therefore, this case was not considered to be an AL. No AL was detected in our AS patients, who were candidates for anti-TNF treatment. One patient showed a discovertebral abnormality on MRI, without a fracture line on conventional radiology. The relative small proportion of patients with a long-established disease might explain this finding for, particularly, an ankylosed spine is prone to develop an AL.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20496041 PMCID: PMC2970813 DOI: 10.1007/s10067-010-1480-9
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 2.980
Fig. 1A lateral radiograph of the lumbar spine shows an Andersson lesion with extensive bony destruction of the L1–L2 disk with irregular endplates and increased sclerosis of adjacent vertebral bodies (from Van Royen et al. with permission)
Baseline characteristics
| Mean ± SD | Range | |
|---|---|---|
| Number | 56 | |
| Age (in years) | 43 ± 10.8 | 22–73 |
| Male gender (%) | 38 | 68 |
| Disease duration (in years)a | 11 ± 8.7 | 1–41 |
| Symptom duration (in years)b | 21 ± 11.3 | 1–49 |
| BASDAI (0–10)c | 6.4 ± 1.4 | 4.0–9.7 |
| Tragus-to-wall distance (cm; normal, <15 cm) | 16 ± 6.0 | 11–44 |
| Lumbar flexion index (cm; normal, >5 cm) | 2.5 ± 1.2 | 0.3–5 |
| Lumbar side flexion (cm; normal, >10 cm) | 10 ± 4.9 | 3.8–19 |
| Chest expansion (cm; normal, >5 cm) | 3.4 ± 1.5 | 0.5–7 |
aDisease duration: mean time between the diagnosis and baseline
bSymptom duration: mean time between the first symptoms and baseline
cBASDAI: bath ankylosing spondylitis disease activity index; mean value, 11
Fig. 2a T1-weighted gadolinium diethylenetriamine pentaacetic acid postcontrast image demonstrated high-signal intensity around the disk margins of T7–T8 and T9–T10. b T1-weighted image shows low-signal intensity bone marrow edema in the adjacent vertebral endplates of the T7/T8 and T9/T10 disk spaces. c T1-weighted image, obtained 24 months after treatment with anti-tumor necrosis factor agents